港股異動丨年度業績超預期,東方甄選升超11%
東方甄選(1797.HK)盤初拉昇一度升11.4%報12.12港元。消息面上,公司上週五晚公佈業績顯示,截至2024年5月31日止年度的年度業績,總營收約70.73億元,同比增長56.82%;公司擁有人應占溢利17.195億元,同比增長77%;經調整溢利約21.81億元,同比增長約1倍;基本每股盈利1.68元。業績發佈後,中金髮布業績點評稱,東方甄選公佈FY24業績(財年截至5月31日):教育業務完成剝離後,FY24持續經營業務收入可比口徑下同比增長68.1%至65.3億元,經調整淨利潤同比下降22.6%至7.09億元,均超出該行此前預期,主要系GMV超預期。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.